NEW YORK, Oct. 29, 2025 — Iris Ventures, the global investment firm behind some of beauty and wellness’s most trailblazing and transformative brands, has made a multimillion-dollar minority investment in Goddess Maintenance Co., a biotech beauty brand pioneering science-backed innovations for lasting hair health and protection.

Founded by Denise Russell, Edward Connaghan, Lauren Vesler and Manda Mason, Goddess Maintenance Co. is redefining professional hair care through a proprietary new category called “bioprotection.” Russell and Connaghan, both early operators behind breakthrough hair care brands Olaplex and K18, joined forces with sisters Vesler and Mason to create a next-generation professional system grounded in biotechnology.

At the heart of the brand is the Goddess Molecule, developed in partnership with biomaterials innovation leader, Bolt. Inspired by the structure of spider silk, celebrated for its extraordinary strength and flexibility, the molecule forms scaffold-like chains that wrap around each strand to defend hair against environmental and chemical damage. The dual-action molecule also penetrates the cuticle to reinforce the structure at the hair’s cortex. The result is a breakthrough chain mail-style protective effect that strengthens from within, reduces styling time, improves manageability and extends salon finishes.

Following the launch of its breakthrough first product BioTech Blowout™ Leave-In Restorative Mask earlier this year, Goddess Maintenance Co. has swiftly built a footprint in more than 100 countries, reflecting the brand’s momentum and the growing global demand for innovation in hair care.

“Partnering with Iris felt like a natural next step,” said Lauren Vesler, CEO of Goddess Maintenance Co. “While we weren’t actively seeking investment, their deep understanding of the beauty industry, unwavering commitment to innovation and belief in our mission to pioneer bioprotection in hair care made them the ideal partner to help us scale our vision globally.”

Iris Ventures’ portfolio includes Maurten (sports nutrition), Olistic (hair health), Healf (well-being retail platform) and Superlativa (women’s supplements), among others. The firm is currently launching its second fund, targeting €200 million, to continue investing in founder-led, purpose-driven consumer brands.

Montse Suarez, founder and managing partner at Iris Ventures, said: “Goddess is at the forefront of science-led beauty, pioneering the bioprotection category and redefining what’s possible in professional hair care. With its proprietary molecule, deep stylist-first approach and global ambition, Goddess is delivering a true breakthrough that bridges the gap between repair and maintenance, transforming how we think about long-term hair health. It’s rare to see a brand so deeply rooted in science yet so emotionally resonant with both professionals and consumers alike.”

“Goddess exemplifies the kind of boundary-breaking innovation we look for: world-class science, a clear mission and a brand built to resonate globally,” said Marc Calzada, Investor, Iris Ventures. “Their leadership team has the ambition and capability to lead the next evolution in professional beauty.”

The new funding will accelerate the brand’s product development pipeline, expand its professional salon partnerships and advance its international expansion strategy.

About Goddess Maintenance Co.
Goddess Maintenance Co. is a biotech beauty company dedicated to advancing the long-term health and vitality of hair through a new category: bioprotection. Built on patented technology developed with Bolt, Goddess Maintenance products strengthen and protect hair from the inside out, merging science and beauty for the professional community worldwide.

About Iris Ventures
Iris Ventures is a global consumer growth investment firm partnering with visionary, founder-led brands across beauty, wellness and lifestyle. Guided by the mission to invest in companies that improve well-being and quality of life, Iris Ventures brings deep industry expertise, strategic resources and a global network to help brands scale sustainably.

MEDIA CONTACT:
[email protected]

SOURCE Goddess Maintenance Co.

The modern homecare brand continues redefining the category through fine-fragrance, design, and craftsmanship

LOS ANGELES, Oct. 29, 2025 — Homecourt, the award-winning home and personal fragrance brand founded by Courteney Cox, has raised an $8 million Series A round led by CULT Capital. The funding will accelerate brand awareness, expand the team, and strengthen infrastructure to support continued growth.

Homecourt has quickly built a cult following since its 2022 launch, expanding from homecare into new categories including body and laundry, and widening distribution channels from DTC to 300+ doors across the US including Nordstrom, Blue Mercury and Revolve. A 4x Allure Best of Beauty Winner, Homecourt has also been recognized by Fast Company as one of the “World’s Most Innovative Companies” and by Inc. as “Best in Business.”

“With less than 5 full-time employees, we’ve doubled the business every year and built a cult brand that’s defining a new category in the beauty industry,” said Sarah Jahnke, Co-founder and CEO.  “This fundraise gives us the resources to accelerate our impact and scale our category leadership.”

“I am unbelievably excited to take this business to the next level. Homecourt is my greatest passion, and bringing on a strategic investment partner like CULT means we can become the global household name I know we can be,” shares Courteney Cox, Founder of Homecourt.

CULT Capital brings deep expertise in scaling consumer brands, and a proven track record in beauty with a portfolio that includes Supergoop!, LAWLESS Beauty, and Act+Acre. With the close of its second fund, CULT continues its focus on backing the rare and remarkable few brands redefining their categories. Known for its highly selective investment approach, CULT reviews hundreds of companies annually but invests in only a handful, underscoring Homecourt’s standout position and extraordinary potential in the beauty industry.

“CULT is thrilled to welcome Homecourt to our family of cult brands,” said Sarah Woelfel, Co-Founder and Partner at CULT Capital. “We see in Courteney an authentic founder with a clear mission to elevate consumers’ homes in a meaningful way, and in Sarah an exceptional CEO who brings the experience and resources to bring that vision to life. Together, they make a powerful team. We’re excited to partner with Courteney, Sarah and existing investors to scale Homecourt through a best-in-class growth strategy, supported by CULT’s deep expertise, operational discipline, and passion for building enduring brands.“

Cult Capital is Homecourt’s only institutional investor. Previously, Homecourt raised money exclusively from friends and family, spearheaded by Bilal Mekkaoui and Ryan Nelson (co-founders of venture studio Jobi Brands).  Homecourt is proud to be majority women-owned and led.

About Homecourt:
Homecourt is a category-defining luxury fragrance and homecare brand founded by Courteney Cox and beauty industry veteran Sarah Jahnke. Bringing beauty, fine-fragrance, and elevated design into everyday rituals, the brand has quickly become a leader in the premium lifestyle and home fragrance space, known for its best-selling cleaning, body, and laundry collections. The brand’s award-winning, non-toxic collection of home, body, and laundry products is available at homecourt.co, Amazon, Nordstrom, Bluemercury, and select independent boutiques.

About CULT Capital:
Founded by John Kenney and Sarah Woelfel in 2015, CULT Capital’s investment philosophy is grounded in identifying and partnering with companies led by passionate entrepreneurs who offer distinctive products with proven product-market fit. The firm is committed to providing capital and strategic support to help emerging consumer brands achieve cult status. Armed with deep expertise and a genuine passion for brand building, CULT Capital has successfully collaborated with a portfolio of consumer brands, including Supergoop!, LAWLESS Beauty, Act+Acre, Elavi, Subtl Beauty, Luna Daily and Hanni among others.  CULT Capital is investing from its second investment fund.

Media Contact:
[email protected]

SOURCE Homecourt

MINNEAPOLIS, Oct. 29, 2025 — VentureMed Group, Inc., a leading medical device company specializing in vessel preparation and access management technologies for the treatment of peripheral arterial disease (PAD) and arteriovenous fistulas and grafts (AVF, AVG), today announced the closing of a $28 million Series C financing round led by S3 Ventures, and joined by existing investors including Endeavour Vision.

“As we enter our next phase, we are grateful for the continued support of our existing investors and excited to welcome new partners to the syndicate,” said Denis Harrington, President and CEO of VentureMed. “This significant financing underscores investor confidence in the FLEX Vessel Prep™ System and our mission to strengthen VentureMed’s position in global vascular care.”

In addition to expanded commercial infrastructure, the funding will also advance VentureMed’s clinical program and support new product development, including new applications in adjacent vascular settings.

“VentureMed is addressing one of the most persistent challenges in vascular access with a technology that is both elegant and transformative,” said Brian R. Smith, Managing Director at S3 Ventures. “Our partnership reflects a shared mission to bring breakthrough treatments to those who need them most.”

Vascular diseases are a growing burden globally, driven by the rise in obesity, diabetes and hypertension. PAD affects more than 20 million people in the U.S. and over 200 million worldwide¹, while stenosis and vessel dysfunction remain major causes of access failure in dialysis patients. FLEX was developed to improve vessel compliance, minimize trauma, and support better long-term outcomes. “Lesion prep is rapidly becoming one of the most important procedures for improving patient outcomes. The FLEX VP system is leading the way in addressing AV Access interventions,” said Dr. Ari Kramer, General Surgeon, Spartanburg Medical Center. “This fundraising is an important milestone as the company advances additional clinical evidence and expanded indications.”

Already FDA 510(k)-cleared, CE Mark-approved, and supported in the U.S. by a dedicated CMS HCPCS code (C1600) with transitional pass-through payment, FLEX is positioned to redefine vessel preparation and potentially expand treatment options worldwide.

“The cycle of re-narrowing and repeat procedures in vascular disease places a significant burden on patients and health systems,” said Alexander Schmitz, Partner at Endeavour Vision. “A technology that reduces the need for reinterventions not only improves outcomes but also aligns with the shift to value-based care. We’re excited to continue supporting VentureMed as it expands access to this important therapy.”

About VentureMed Group & FLEX Vessel Prep™ System
VentureMed Group, Inc. is a pioneering privately held medical device company based in Minnesota dedicated to advancing endovascular solutions for arteriovenous (AV) access and peripheral arterial disease (PAD) interventions. The company’s flagship technology, the FLEX Vessel Prep™ System, is an FDA 510(k)-cleared and CE Mark-approved device, that is designed to optimize vessel preparation using its proprietary Kinetic Endovascular Micro-incision Creation (KEMIC) technology. Unlike traditional balloon-based approaches that apply static pressure, KEMIC leverages controlled motion and dynamic vessel apposition to create long, precise micro-incisions. This unique mechanism facilitates luminal gain, may enhance drug uptake when used in combination therapy, and may reduce vessel trauma – ultimately lowering the risk of restenosis. For more information, visit www.VentureMedgroup.com.

References: 1. Allison M.A. et al.Circulation. 2023;148:286–296.

Media contact: Tom Michals
[email protected]
+1(763) 951-0280

Logo – https://mma.prnewswire.com/media/658751/VentureMed_Group_Logo.jpg

As wage pressures, regulation, and caregiver shortages strain post-acute providers, Arya is using AI to automate non-clinical administration, freeing resources to focus on care

NEW YORK, Oct. 29, 2025 — Arya Health (Arya), an AI company helping home health and post-acute care providers automate scheduling, compliance, and other administrative operations, announced today its $18.2 million Series A funding. The round was led by ACME Capital, with participation from Ridge Ventures, Twelve Below, executives from OpenAI, and leading post-acute care providers, bringing Arya’s total funding to $25 million.

Post-acute care providers, including home healthcare agencies, hospice providers, and long-term care facilities, are facing unprecedented strain. Rapid regulatory changes, caregiver shortages, and escalating wage pressures are pushing an already margin-constrained industry to the brink. Meanwhile, heavy private equity investment and consolidation call for a renewed focus on operational excellence and thinking beyond the traditional “people-heavy” approach to post-acute care administration.

Arya is building a new AI-native “system of action” that sits alongside the Electronic Medical Record (EMR) to automate the heavy administrative load that burdens front office teams, slows growth, and diverts resources from patient care and caregiver support.

“Post-acute care organizations spend roughly 25 cents of every dollar on non-clinical tasks,” said Kunal Sarda, CEO and co-founder of Arya Health. “That’s time and money that should be going toward caregivers and patients, not process. Arya is flipping that equation by using AI to take on the operational burden so providers can focus on delivering care, not moving patients, caregivers, and data around in their EMR. Our mandate is to make post-acute care administration more scalable, human, and cost-effective at the same time.”

Arya’s AI-powered digital agents automate key post-acute care workflows, including caregiver scheduling, compliance tracking, and hiring pipeline management. Embedded in daily operations, these agents continuously learn and adapt to increase workforce efficiency. Recent innovations include the Onboarding Agent, which reduces time-to-first-staffing by 50% with 70% less administrative effort; the Talent Acquisition Agent, which autonomously recruits and schedules caregivers with 60% less human effort; and the Compliance Agent, which eliminates manual license tracking and deploys in just one week. The company is also preparing to launch an Intake Agent in Q4, designed to accelerate patient start of care and reduce critical back-office bottlenecks.

The new funding will enable Arya to expand its product suite across additional administrative functions and scale hiring to keep pace with market demand. Arya has grown revenue more than 6x in 2025 and is on track for 10x year-over-year growth by year-end.

As part of this next phase, Arya has appointed Melinda Phillips, former CEO of Thrive Skilled Pediatric Care (acquired by Aveanna), to lead its Care@Home Center of Excellence, where she will help scale AI adoption across the home care sector. A veteran operator of one of the nation’s largest post-acute providers, she brings deep industry experience to Arya’s technology-driven team, strengthening the company’s blend of insider expertise and outsider innovation.

“Arya represents exactly the kind of innovation post-acute care needs right now,” said Aike Ho, Partner at ACME Capital. “They’re pairing deep operational expertise with cutting-edge AI to unlock entirely new economics for providers, without sacrificing the humanity at the heart of care.”

To learn more, visit www.aryahealth.ai.

About Arya Health
Arya Health builds AI-powered digital agents that eliminate the administrative burden in post-acute care-so caregivers and coordinators can focus on patients, not processes. Purpose-built for home health, home care, and hospice, Arya integrates with leading EMRs to automate scheduling, compliance, onboarding, and more. By replacing manual office work with intelligent automation, Arya helps agencies cut costs, boost caregiver utilization, and scale efficiently-while keeping humanity at the heart of care.

Media contact:
BAM for Arya Health
[email protected] 

SOURCE Arya Health / BAM

Represents Ericsson’s latest AI investment as Voxel leads transformation from reactive to proactive workplace safety

SAN FRANCISCO, Oct. 29, 2025 — Voxel, the computer vision AI company revolutionizing workplace safety and risk, today announced a strategic investment from Ericsson Ventures, part of the Ericsson Group (NASDAQ: ERIC), a world leader in communications technology, offering hardware, software, and services to enable connectivity. This funding marks the latest significant investment Ericsson has made out of their Artificial Intelligence (AI) program.

Voxel recently completed a $44M Series B funding round, which was led by NewRoad Capital Partners with participation from Eclipse, Rite-Hite, Tokio Marine, MTech, HG Ventures and Whitestone. This round brings the company’s total funding of $64 million to date.

“This investment represents more than capital – it’s a strategic partnership built on shared vision,” said Vernon O’Donnell, CEO of Voxel. “Following our Series B, we’re focused on scaling our impact, and Ericsson brings both the global reach and technical expertise to help us transform workplace safety across industries worldwide.”

Jose Suarez, Head of Ericsson Ventures said, “Ericsson is committed to workplace safety as a core value. Voxel’s platform delivers tangible results, reducing workplace incidents and delivering immediate ROI to customers. We are excited to partner with Voxel to help companies protect their most important assets – their people.”

Voxel is hiring across all business units and offices. Open positions can be found here. To learn more about the solutions Voxel offers, please book time with our team.

About Voxel
Voxel is revolutionizing workplace safety with its AI-powered site visibility platform, designed to help organizations identify and mitigate risks in industrial environments. Using existing cameras, Voxel transforms basic video footage into actionable insights, enabling organizations to proactively make workplaces safer and more effective.

Voxel partners with businesses across industries such as warehousing, manufacturing, distribution, and insurance. By equipping businesses with the tools to identify risks before they happen, Voxel powers safer, more effective work environments.

SOURCE Voxel

The Partnership Pioneers New Pathways to Prepare for the Women’s Wealth Wave (™)

HOUSTON, Oct. 29, 2025 — In a first-of-its-kind collaboration set to reshape the financial landscape, Stavis Wealth and Curate Capital today announced a shared mission to unite the worlds of venture capital and wealth management, creating a powerful ecosystem where female founders, investors, and advisors can build, scale, and sustain wealth.

Both female-founded and female-led, the two firms share a bold vision: to close the gender wealth gap, rewrite outdated business models, and deliver integrated solutions that support women at every stage of their financial journeys, from launching their first company to preserving a multigenerational legacy.

The collaboration marks an expansion of the Women’s Wealth Wave (™), a Stavis Wealth initiative to educate, equip, and empower women but also to expand their access to meaningful financial opportunities. The initiative combines actionable learning, mentorship, and community with strategic partnerships, including ventures like Curate Capital, that connect women directly to capital, investment insights, and long-term planning resources. It builds on Stavis Wealth’s white-glove approach to holistic wealth management and legacy design, reflecting the firm’s long-standing commitment to advancing women’s financial confidence, access, and impact.

Curate Capital, founded by Carrie Colbert, has redefined venture capital by pioneering the concept of Influential Investing(™), leveraging the capital and talents of top-tier creators to power the growth of the brands in which they invest. The firm’s concept creates a win-win-win scenario for influencers, founders, and investors.

“The future of wealth creation isn’t about keeping investing and planning apart but about connecting them,” said Deborah Stavis, Founder and CEO of Stavis Wealth. “Because we’re an independent firm, with direct involvement alongside the Curate leadership team, our clients gain visibility and access to innovative opportunities. When investments are woven together with long-term planning to build real legacy, it creates a level of coordination and opportunity that most wealth management firms just aren’t built to deliver.”

Founded in 2020, Curate Capital has raised more than $30 million and invested in more than 20 women-led companies, including Frances Valentine, Live Tinted, Nori, and Curie, demonstrating that empowering women-led innovation isn’t just good business; it’s reshaping consumer categories. In fact, data shows that women control a staggering 85% of consumer spending. Curate believes that women are now building the solutions that they wish existed. 

“Originally as a venture capital outsider, I sought to bring a fresh perspective to the asset class, identifying two key gaps – women being underfunded despite overdelivering and a stagnant venture capital model ripe for innovation – and set out to address both,” said Carrie Colbert, Founding and General Partner of Curate Capital. “Women are redefining what wealth looks like and how it’s created. By aligning with Deborah and her team, we’re building a platform that helps women grow businesses, exit successfully, and translate those wins into enduring, multi-generational wealth.”

The partnership is also a direct response to one of the most persistent inequities in finance: women-led venture capital firms still receive less than 2% of total VC funding, and female advisors remain underrepresented in wealth management. Together, Stavis Wealth and Curate Capital aim to change that. Not only by investing in women and supporting female-led companies, but by cultivating the next generation of women investors, advisors, and industry leaders through mentorship.

This collaboration marks a pivotal step toward a future where financial empowerment isn’t an afterthought, it’s built into the foundation of entrepreneurship. Together, Stavis Wealth and Curate Capital are championing a new model for wealth creation: one that’s inclusive, intentional, and deeply transformative.

About Stavis Wealth
Stavis Wealth is a Houston-based wealth management firm providing comprehensive, holistic financial planning, investment management, estate planning, and customized life insurance solutions under one roof. Founder Deborah Stavis has served Houston families for over 35 years as a private wealth manager, having owned and operated two successful Registered Investment Advisory (RIA) firms, each amassing roughly 1 billion dollars in AUM. With this third round, Stavis Wealth is raising the bar once again, delivering a level of client experience and service excellence that other firms simply can’t match. Through initiatives like Women’s Wealth Wave(™), Stavis Wealth equips women with the education, strategies, and community to lead with confidence and protect their family legacy for generations.

About Curate Capital
Curate Capital is a Houston-based venture capital firm founded in 2020 by Carrie Colbert and dedicated to investing in female-founded consumer brands. Curate invests in extraordinary women building the products, services and technology the consumer wants for herself, her family and her life. Curate harnesses the power of influencers through its Influential Investing(™) program to directly impact portfolio company growth and drive outsized investor returns. Curate has invested in 20+ companies across categories like health & beauty, food & beverage, home & family, and fashion & apparel.

SOURCE Stavis Wealth

User Base Grows 483% in One Quarter as AI-Generated Code Outpaces Traditional Testing Capabilities

SEATTLE, Oct. 29, 2025 — TestSprite, the agentic testing tool for AI-native development, today announced the close of a $6.7 million seed round, bringing total funds raised to approximately $8.1 million. Trilogy Equity Partners led the round, with participation from both new and existing investors, including Techstars, Jinqiu Capital, MiraclePlus, Hat-trick Capital, Baidu Ventures, and EdgeCase Capital Partners. TestSprite is scaling to meet surging demand, growing 6X over the last three months, reaching over 35,000 users, following the launch of TestSprite 2.0 and its MCP server. The funding comes at a pivotal time, as the rise of AI-powered coding tools like Cursor, Windsurf, and GitHub Copilot accelerates development speed but creates a critical new bottleneck: testing and validating AI-generated code at scale. The oversubscribed round further cements TestSprite’s position as the testing backbone of the AI-native software development era.

Gartner projects that 90% of enterprise developers will use AI-assisted tools by 2028, up from under 14% in early 2024, indicating a massive total addressable market (TAM) exceeding $30–50 billion in the coming years. Andrew Ng, a globally recognized leader in AI and co-founder of Google Brain and founder of DeepLearning.AI, noted, “As AI gets better at generating code, ensuring that code works as intended becomes even more important. Reliable evaluation pipelines are critical for scaling trustworthy AI systems.”

“We’re witnessing a fundamental shift in software development. While everyone focuses on AI writing code faster, the real constraint is validation. TestSprite is the first to solve testing at the speed of AI, and the rapid growth quarter-over-quarter proves developers are desperate for this solution,” said Yuval Neeman, Managing Director, at Trilogy Equity Partners.

“Writing code is no longer the hard part—the real challenge is ensuring it behaves exactly as intended,” said Yunhao Jiao, CEO and co-founder of TestSprite. “AI coding tools like Cursor have made development 10x faster, but they’ve also created a new risk bottleneck: testing and validation can’t keep up. TestSprite is the autopilot layer that turns AI-written code into production-ready software without the manual testing overhead that’s slowing teams down.”

Many developers now find that vibe coding, building quickly with AI copilots, can become more frustrating and time-consuming than traditional development when debugging begins. TestSprite seeks to remove that pain entirely. Early adopters report cutting testing cycles from days to minutes, enabling teams to ship multiple releases per week instead of monthly.

TestSprite’s autonomous agent works directly inside AI IDEs and through MCP integration, enabling test-driven development throughout the coding process, not as a separate phase after code is written. TestSprite integrates natively into developers’ workflows, allowing developers to test without context switching to browsers or separate testing platforms. Developers validate and refine code iteratively as they build, producing production-ready software at completion without leaving their development environment.

TestSprite’s AI automatically generates frontend and backend tests, executes them, diagnoses failures, and proposes potential fixes through simple natural language commands. By enabling agentic testing where TestSprite’s AI agent writes, runs, and updates tests autonomously, it acts as an autopilot for software testing, dramatically accelerating developer velocity while maintaining quality.

TestSprite plans to channel funds toward expanding its engineering team to deepen capabilities in test generation, AI-powered test healing, and intelligent monitoring, while scaling infrastructure to support teams deploying thousands of code changes daily. TestSprite aims to become the industry standard testing layer for AI-native development by mid-2026.

About TestSprite
Based in Seattle, Washington, TestSprite is building the testing backbone for AI-native software development. Its MCP server integrates directly into developers’ AI IDEs, enabling continuous, test-driven development where code is validated iteratively throughout the entire build process—not just after it’s written. By supporting agentic coding workflows, where AI can autonomously write, test, and validate code, TestSprite functions as an autopilot for software quality, helping developers ship production-ready software at AI speed. Today, TestSprite powers the workflows of over 35,000 users from leading companies, such as Google, Apple, Adobe, Salesforce, ByteDance, Microsoft, and Meta, building the next generation of AI-native applications. Learn more at www.testsprite.com.

Press Contact:
Carmen Hughes
Ignite X
[email protected]
650.576.6444

SOURCE TestSprite

CustoMED’s cloud-based platform combines artificial intelligence and automation with 3D printing to generate surgical tools and implants directly from a surgeon’s pre-operative plan within minutes instead of weeks. The patient-specific devices are produced onsite or through certified partners and integrate seamlessly into existing surgical workflows, enabling fewer intraoperative errors and more predictable outcomes while allowing surgeons to maintain full creative and clinical control. The technology has already been used in hundreds of successful surgeries worldwide, with thousands more planned for the coming year.

“CustoMED’s patient-specific surgical tools enable more precise orthopedic surgeries through affordable, real-time solutions delivered directly into the operating room,” said Or Benifla, Co-founder of CustoMED. “By putting scalable, personalized technology directly in surgeons’ hands, our mission is to make computer-guided surgery fast, accessible, and routine, transforming what was once a boutique process into standard of care for every patient.”

CustoMED was founded by Dr. Amit Zabatani, Or Benifla, and Alon Jacobi, and originated from Sheba Medical Center’s 3D Printing & Innovation Lab, founded in 2018 by Dr. Dina Orkin together with the CustoMED co-founders. The lab has supported hundreds of surgeries across multiple hospital departments, making 3D technologies a routine part of patient care. CustoMED is part of Sheba Medical Center’s ARC Innovation ecosystem, which fosters clinician-led innovations and accelerates global deployment.

“CustoMED is embedding precision and surgeon-directed tools into everyday workflows, shortening the path from imaging to the operating room while preserving governance, quality, and safety,” said Prof. Eyal Zimlichman, Founder and Director of ARC Innovation and Chief Innovation, Transformation, and AI Officer at Sheba Medical Center. “The company exemplifies ARC’s mission to translate clinical insight into scalable, real-world impact.”

Funding proceeds will accelerate CustoMED’s expansion into additional automated orthopedic indications, support U.S. and EU regulatory milestones—with approvals anticipated for 2026—and enable the global deployment of its on-demand manufacturing model.

“We were immediately impressed by the ARC team’s world-class experience and CustoMED’s mission to improve surgical performance and patient outcomes,” added Raissa Hacohen, Managing Partner at Longevity Venture Partners. “CustoMED’s platform gives surgeons everywhere access to personalized planning and surgical tools that can raise the standard of care in orthopedic surgery.”

About CustoMED

CustoMED is a surgeon-first platform for AI-powered, patient-specific orthopedic surgery. Originating from Sheba Medical Center’s 3D Printing & Innovation Lab, CustoMED applies AI-driven automation and 3D printing to transform surgeons’ decisions into surgical guides and implants perfectly tailored to each patient. With hundreds of successful surgeries performed worldwide and $6M raised to date, CustoMED is scaling its solutions globally.

About ARC

ARC (Accelerate, Redesign, Collaborate), the innovation arm of Sheba Medical Center, founded and directed by Prof. Eyal Zimlichman, is shaping the future of medical innovation by connecting entrepreneurs and clinicians, advancing the development and implementation of new technologies, and creating breakthrough economic frameworks in healthcare. ARC’s unique model—the first of its kind in global healthcare—has evolved into a global blueprint, with a network of innovation centers in leading hospitals and research institutions across London, Melbourne, Singapore, Berlin, and New Zealand. ARC’s global network promotes technology-based medical solutions and accelerates the adoption of innovation within health systems worldwide.

ARC provides startups and researchers with exclusive access to Sheba’s core assets, clinical data and medical talent, while advancing the hospital’s vision to serve as a global hub for AI-driven medicine. The model’s success has already led to exits totaling approximately $1 billion, with profits reinvested to further accelerate Sheba’s AI and data revolution.

About Sheba Medical Center

The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and AI-based healthcare transformation. Sheba’s City of Health boasts acute-care, rehabilitation, children’s, cancer and geriatric hospitals, research and innovation hubs, medical simulation center, center for disaster response and a virtual hospital on one comprehensive campus in the center of Israel. Sheba serves as a true hospital without borders, welcoming patients and healthcare professionals from all over the world and consistently providing the highest-level medical care to all in need. For more information, visit: https://sheba-global.com

Photo – https://mma.prnewswire.com/media/2808183/MADE_by_SURGEONS.jpg

Contact:
Aviva Sapir 
Number 10 Strategies 
[email protected] 

SOURCE CustoMED

Fast growing National Security focused company adds additional resources to scale its Counter-UAS and Cybersecurity solutions

COLUMBIA, Md., Oct. 29, 2025 — BTS Software Solutions (BTS), a veteran-owned, fast-growing provider of intelligence operations, counter-UAS, cybersecurity, and data science solutions to national security focused agencies has announced a venture capital investment from Blue Delta Capital Partners, a growth-stage venture capital firm focused exclusively on the U.S. Federal Government market. The BTS management team will continue to be the majority owners of the company and will lead the veteran-owned firm to new heights. 

BTS is excited about this significant milestone in the Company’s evolution, with Blue Delta providing the equity capital, additional resources, and industry expertise needed to further enhance the Company’s proven capabilities for its national security customers, support future strategic acquisitions, and expand its impact to the Nation’s missions.

“We are delighted to secure this investment from Blue Delta as we embark on the next chapter in BTS’s growth,” said David Tohn, CEO of BTS. “Blue Delta’s deep and proven expertise in the national security market and their successful track record with companies like ours make them an ideal partner for our team as we continue to drive innovation for our national security and homeland defense customers and deliver unparalleled value to our Nation’s missions.”

“BTS has built an impressive reputation for delivering mission-critical solutions to our country’s national security customers and we are flattered to have the opportunity to back David and Dan and their team in supporting their growth plans, helping to amplify their impact in our core market,” said Kevin Robbins, co-founder of Blue Delta Capital Partners.

Dan Cummings, COO of BTS, added, “We are excited to have Blue Delta on our team, further accelerating our growth trajectory in counter-UAS and cybersecurity, while they also are fully aligning with BTS’s core values of Mission focus and dedication to our employees and customers.”

Assistance on the transaction for BTS came from Tidelock Partners, Next-Stage Partners, Miles & Stockbridge BDO, RSM and Aprio, while Blue Delta was assisted by Holland & Knight.

About  BTS
BTS Software Solutions (BTS) is a veteran-owned, fast-growing provider of intelligence operations, counter-UAS, cybersecurity, and data science solutions to national security focused agencies. Learn more at www.unleashbts.com.

About Blue Delta Capital Partners
Blue Delta, a growth-stage venture capital firm founded in 2009, focuses on the U.S. federal government services market. Learn more at www.bluedeltacapitalpartners.com

SOURCE BTS Software Solutions